Working with mice, a multicenter team of researchers has found a new way to reduce the abnormal blood vessel growth and leakage in the eye that accompany some eye diseases. The finding could lead to the development of new ...
Sep 3, 2014
0
0
In a study published online by JAMA Ophthalmology, Gwyneth Rees, Ph.D., of the University of Melbourne, Australia, and colleagues examined the association between severity of diabetic retinopathy and diabetic macular edema ...
Jul 7, 2016
0
4
A randomized controlled trial involving patients with persistent clinically significant diabetic macular edema (swelling of the retina) suggests the greater efficacy of bevacizumab compared with macular laser therapy that ...
Apr 9, 2012
0
0
(HealthDay)—Intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment is not associated with increased risk of systemic adverse events for patients with neovascular age-related macular degeneration, diabetic ...
Mar 26, 2018
0
2
For patients with diabetes, an automated binary diabetic macular ischemia (DMI) algorithm using optical coherence tomography angiography (OCTA) images predicts diabetic retinal disease progression and deterioration of visual ...
May 31, 2023
0
27
Researchers at St. Michael's Hospital have found a biomarker from fluid in the eye that predicts which patients will respond best to current treatments for diabetic macular edema, one of the most common complications of diabetes.
Mar 8, 2018
0
2
In a randomized clinical trial of more than 300 participants, researchers from Johns Hopkins and elsewhere have found that ranibizumab—a drug most commonly used to treat retinal swelling in people with diabetes—is an ...
Nov 17, 2015
0
9
(HealthDay)—For patients with diabetic macular edema (DME), persistence is more likely with bevacizumab than with aflibercept or ranibizumab, according to a study published online Feb. 1 in JAMA Ophthalmology.
Feb 4, 2018
0
4
Researchers have developed a novel synthetic protein to treat macular degeneration and other incurable eye diseases that lead to blindness in millions of people. It is the first drug of its kind and is currently in human ...
Jul 25, 2023
0
1
The odds of having diabetic macular edema (DME), a leading cause of vision loss in patients with diabetes mellitus, appears to be higher in non-Hispanic black patients than white patients, as well as in those individuals ...
Aug 14, 2014
0
0
